GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (XTER:PSH) » Definitions » Pre-Tax Income
中文

Sernova (XTER:PSH) Pre-Tax Income : C$-40.73 Mil (TTM As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

Sernova Pre-Tax Income Definition

Pretax income is the income that a company earns before paying income taxes. Sernova's pretax income for the three months ended in Jan. 2024 was C$-9.74 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jan. 2024 was C$-40.73 Mil. Sernova's pretax margin was %.


Sernova Pre-Tax Income Historical Data

The historical data trend for Sernova's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.97 -5.32 -6.97 -24.42 -39.00

Sernova Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.02 -9.35 -9.93 -11.70 -9.74

Competitive Comparison

For the Biotechnology subindustry, Sernova's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Pre-Tax Income Distribution

For the Biotechnology industry and Healthcare sector, Sernova's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Sernova's Pre-Tax Income falls into.



Sernova Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Sernova's Pretax Income for the fiscal year that ended in Oct. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-40.502+0.036+-0.032+1.5+0
=-39.00

Sernova's Pretax Income for the quarter that ended in Jan. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-10.028+0.129+-0.01+0.166+0
=-9.74

Pre-Tax Income for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-40.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova  (XTER:PSH) Pre-Tax Income Explanation

Sernova's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-9.743/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Sernova's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova (XTER:PSH) Business Description

Traded in Other Exchanges
Address
700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.

Sernova (XTER:PSH) Headlines